GENEVIEVE LYNCH: Open Payments
NPI 1417226655 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 21 payments from 5 companies in 2025. Trend: 2023 $656 · 2024 $480 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $271 |
| SCPHARMACEUTICALS INC. | 10 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $94 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: CARDIOMEMS, FUROSCIX, SPRAVATO, AMVUTTRA.
Industry payments across CA — which companies pay providers there.
